[1] 王晓艳,张娜,高学军,等.奶牛乳腺对血液游离氨基酸吸收的差异性研究[J].中国乳品工业,2013,41(1):8-10,14.
[2] 秦宜德,邹思湘.乳蛋白的主要组分及其研究现状[J].生物学杂志,2003,20(2):5-7.
[3] DOS REIS C B M,BARREIRO J R,MESTIERI L,et al.Effect of somatic cell count and mastitis pathogens on milk composition in Gyr cows[J].BMC Veterinary Research,2013,9(2):67.
[4] 陈静廷,马露,杨晋辉,等.差异蛋白质组学在乳蛋白研究中的应用进展[J].动物营养学报,2013,25(8):1683-1688.
[5] ZHOU Y,SONG F,LI Y S,et al.Double-antibody based immunoassay for the detection of β-casein in bovine milk samples[J].Food Chemistry,2013,141(1):167-173.
[6] GARDNER B,FELDMAN J.Are positive axillary nodes in breast cancer markers for incurable disease?[J].Annals of Surgical,1993,218(3):270-275.
[7] BIONAZ M,LOOR J J.Gene networks driving bovine mammary protein synthesis during the lactation cycle[J].Bioinformatics and Biology Insights,2011,5:83-98.
[8] 王光文.提高乳蛋白的综合技术[J].乳业科学与技术,2007,30(1):29-35.
[9] HAYASHI A A.Regulation of protein synthesis in the mammary gland[D].Palmerston North:Massey University,2007:12-15.
[10] FRASOR J,BARKAI U,ZHONG L,et al.PRL-induced ERalpha gene expression is mediated by Janus kinase 2(JAK2) while signal transducer and activator of transcription 5b (STAT5b) phosphorylation involves JAK2 and a second tyrosine kinase[J].Molecular Endocrinology,2001,15(11):1941-1952.
[11] COOPER J C,BOUSTEAD J N,YU C L.Characterization of STAT5B phosphorylation correlating with expression of cytokine-inducible SH2-containing protein (CIS)[J].Cellular Signalling,2006,18(6):851-860.
[12] LEVY D E,DARNELL J E.STATs:transcriptional control and biological impact[J].Nature Reviews Molecular Cell Biology,2002,3(9):651-662.
[13] HARDIE G D.AMP-activated/SNF1 protein kinases:conserved guardians of cellular energy[J].Nature Reviews Molecular Cell Biology,2007,8(10):774-785.
[14] BRAZIL D P,HEMMINGS B A.Ten years of protein kinase B signalling:a hard Akt to follow[J].Trends in Biochemical Sciences,2001,26(11):657-664.
[15] 綦松智,吴登俊,张中显.mTOR对信号通路调控的研究进展[J].中国畜牧杂志,2010,46(1):57-60.
[16] HAY N,SONENBERG N.Upstream and downstream of mTOR[J].Genes & Development,2004,18(16):1926-1945.
[17] XU G,ZHANG W,BERTRAM P,et al.Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors[J].International Journal of Oncology,2004,24(4):893-900.
[18] PENE F,CLAESSENS Y E,MULLER O,et al.Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma[J].Oncogene,2002,21(43):6587-6597.
[19] PROUD C G.Amino acids and mTOR signalling in anabolic function[J].Biochemical Society Transactions,2007,35(5):1187-1190.
[20] BEUGNET A,TEE A R,TAYLOR P M,et al.Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid avail ability[J].Biochemical Journal,2003,372(2):555-566.
[21] BURGOS S A,DAI M,CANT J P.Nutrient availability and lactogenic hormones regulate mammary protein synthesis through the mammalian target of rapamycin signaling pathway[J].Journal of Dairy Science,2010,93(1):153-161.
[22] 陈洪菊,屈艺,母得志.mTOR信号通路的生物学功能[J].生命的化学,2010,30(4):555-561.
[23] LYNCH C J.Role of leucine in the regulation of mTOR by amino acids:revelations from structure-activity studies[J].The Journal of Nutrition,2001,131(3):861S-865S.
[24] GUNTHER J,ESCH K,POSCHADEL N,et al.Comparative kinetics of
Escherichia coli-and
Staphylococcus aureus-specific activation of key immune pathways in mammary epithelial cells demonstrates that
S.aureus elicits a delayed response dominated by interleukin-6(IL-6) but not by IL-1A or tumor necrosis factor alpha[J].Infection and Immunity,2011,79(2):695-707.
[25] LIU B,ZHANG N S,LIU Z C,et al.RP105 involved in activation of mouse macrophages via TLR2 and TLR4 signaling[J].Molecular and Cellular Biochemistry,2013,378(1/2):183-193.
[26] YOSHIMURA A,NAKA T,KUBO M.SOCS proteins,cytokine signalling and immune regulation[J].Nature Reviews Immunology,2007,7(6):454-465.
[27] ENDO T A,MASUHARA M,YOKOUCHI M,et al.A new protein containing an SH2 domain that inhibits JAK kinases[J].Nature,1997,387(6636):921-924.
[28] ZHENG J M,WATSON A D,KERR D E.Genome-wide expression analysis of lipopolysaccharide-induced mastitis in a mouse model[J].Infection and Immunity,2006,74(3):1907-1915.
[29] JIANG L,SØRENSEN P, RØNTVED C,et al.Gene expression profiling of liver from dairy cows treated intra-mammary with lipopolysaccharide[J].BMC Genomics,2008,9(1):443.
[30] TAMIYA T,KASHIWAGI I,TAKAHASHI R,et al.Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways:regulation of T-cell inflammation by SOCS1 and SOCS3[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2011,31(5):980-985.
[31] YAN C G,CAO J,WU M,et al.Suppressor of cytokine signaling 3 inhibits LPS-induced IL-6 expression in osteoblasts by suppressing CCAAT/enhancer-binding protein β activity[J].Journal of Biological Chemistry,2010,285(48):37227-37239.
[32] RAM P A,WAXMAN D J.SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms[J].Journal of Biological Chemistry,1999,274(50):35553-35561.
[33] KIMURA A,NAKA T,MUTA T,et al.Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT[J].Proceedings of The National Academy of Sciences of the United States of America,2005,102(47):17089-17094.
[34] KREBS D L,HILTON D J.SOCS:physiological suppressors of cytokine signaling[J].Journal of Cell Science,2000,113(16):2813-2819.
[35] HUANG Y L,ZHAO F,LUO C C,et al.SOCS3-mediated blockade reveals major contribution of JAK2/STAT5 signaling pathway to lactation and proliferation of dairy cow mammary epithelial cells
in Vitro[J].Molecules,2013,18(10):12987-13002.
[36] TORNATORE L,THOTAKURA A K,BENNETT J,et al.The nuclear factor kappa B signaling pathway:integrating metabolism with inflammation[J].Trends in Cell Biology,2012,22(11):557-566.
[37] PARK S,ZHAO D W,HATANPAA K J,et al.RIP1 activates PI3K-Akt via a dual mechanism involving NF-κB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN[J].Cancer Research,2009,69(10):4107-4111.
[38] OP DEN KAMP C M,LANGEN R C,SNEPVANGERS F J,et al.Nuclear transcription factor κB activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia[J].American Journal of Clinical Nutrition,2013,98(3):738-748.
[39] SRIVASTAVA D S L,DHAULAKHANDI D B.Role of NF-κB in loss of skeletal muscle mass in cancer cachexia and its therapeutic targets[J].American Journal of Cancer Biology,2013,2(1):1-16.
